Morning home blood pressure may be a significant marker of nephropathy in Japanese patients with type 2 diabetes: ADVANCED-J study 1. (Q42625784)

4 November 2017

title

Morning home blood pressure may be a significant marker of nephropathy in Japanese patients with type 2 diabetes: ADVANCED-J study 1. (English)

1 reference

4 November 2017

1 reference

Yasushi Tanaka

1

1 reference

4 November 2017

Hiroyuki Daida

2

1 reference

4 November 2017

Yutaka Imai

3

1 reference

4 November 2017

Katsumi Miyauchi

4

1 reference

4 November 2017

Yasukazu Sato

5

1 reference

4 November 2017

Masao Hiwatari

6

1 reference

4 November 2017

Akira Kitagawa

7

1 reference

4 November 2017

Junji Kishimoto

8

1 reference

4 November 2017

Tsutomu Yamazaki

9

1 reference

4 November 2017

Ryuzo Kawamori

10

1 reference

4 November 2017

publication date

26 June 2009

1 reference

4 November 2017

published in

Hypertension Research

1 reference

4 November 2017

volume

32

1 reference

4 November 2017

issue

9

1 reference

4 November 2017

page(s)

770-774

1 reference

Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75).

4 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.96

Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.96

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.96

Discrepancy between screening blood pressure and ambulatory blood pressure: a community-based study in Ohasama

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.96

Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure measurement: a population-based observation in Ohasama, Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.96

Amlodipine versus angiotensin II receptor blocker; control of blood pressure evaluation trial in diabetics (ADVANCED-J)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.96

Characterization of plasma brain natriuretic peptide level in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.96

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.96

Masked hypertension, urinary albumin excretion rate, and echocardiographic parameters in putatively normotensive type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.96

Comparing office-based and ambulatory blood pressure monitoring in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.96

7 January 2021

Ambulatory blood pressure monitoring in hypertensive patients with high cardiovascular risk: a cross-sectional analysis of a 20 000-patient database in Spain

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.96

7 January 2021

Plasma brain natriuretic peptide levels in normotensive noninsulin-dependent diabetic patients with microalbuminuria

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.96

7 January 2021

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.96

7 January 2021

Usefulness of home blood pressure measurement in the morning in type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.96

7 January 2021

White coat hypertension in NIDDM patients with and without incipient and overt diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.96

7 January 2021

Identifiers

DOI

10.1038/HR.2009.96

1 reference

release_juznu2azsjeevch4kv5j6wkra4

4 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/juznu2azsjeevch4kv5j6wkra4

24 November 2022

mapped directly with Wikidata item

1 reference